As shown in Figure 2E, CDK6, EPCAM and CCND1 are frequently mutated in CRC, and mutations rates in TP53, KRAS and PIK3CA are also high in the FDG high mCRC patients. This evidence concerns the gene CDK6 and colorectal carcinoma.